Baird Maintains Neutral on Sabra Health Care REIT, Raises Price Target to $21

Benzinga · 3d ago
Baird analyst Vikram Malhotra maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and raises the price target from $20 to $21.